<DOC>
	<DOCNO>NCT02012998</DOCNO>
	<brief_summary>To evaluate immune response Hepatitis B virus child prim HEXAVAC INFANRIX HEXA 10 year ago .</brief_summary>
	<brief_title>Study Immunogenicity Safety Challenge Dose HBVAXPRO Healthy Children Vaccinated 10 Years Ago With 3 Doses HEXAVAC INFANRIX HEXA</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Healthy child Child vaccinate 3 dos HEXAVAC 3 dos INFANRIX HEXA infant Child vaccinate third dose HEXAVAC INFANRIX HEXA least 10 year prior challenge dose Receipt 3 dos Hepatitis B contain vaccine History clinical diagnosis infection due Hepatitis B History current close contact know carrier Hepatitis B virus Prior know sensitivity allergy component HBVAXPRO Chronic illness / medical condition could interfere study conduct completion Coagulation disorder would contraindicate intramuscular injection Subject pregnant Receipt corticosteroid 14 day 30 day prior study Receipt Immunoglobulins , blood bloodderived product 3 month prior study Planned participation another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>